President Trump has resumed his approach of big threats against some trading
partners and generous pacts with others.
·
President
Donald Trump
has resumed his trade strategy of combining major trade deals with aggressive tariff threats
against trading partners.
·
The administration
is pursuing a broad nuclear
cooperation agreement with Saudi Arabia, expected to generate billions of dollars in contracts
for U.S. nuclear companies, particularly Westinghouse.
·
The proposed
agreement could eventually allow Saudi
Arabia to enrich uranium under U.S. supervision through a secure
"black box" technology
arrangement, without transferring sensitive nuclear technology.
·
The deal
aims to strengthen U.S.–Saudi
relations amid heightened tensions with Iran.
·
Critics
warn the agreement could increase the risk of nuclear weapons proliferation, as Saudi Arabia
would not be bound by the stricter non-proliferation conditions imposed on the UAE in its 2009 nuclear agreement.
·
President
Trump announced that generic
drug manufacturers must shift production to the United States within two years
or face a 100% tariff from
2028, rising to 200%
in 2029.
·
The administration
says the measure is intended to boost domestic
pharmaceutical manufacturing and reduce dependence on foreign production.
·
Analysts
caution that higher tariffs on generic medicines could increase healthcare costs
for American consumers.
·
The administration
has also renewed tariff threats
against Canada, reinforcing its strategy of using trade measures
as leverage in negotiations.
·
The broader
approach reflects Trump's continued policy of using "carrots and sticks"—offering
economic incentives to strategic partners while imposing tariffs on countries viewed
as acting unfairly.
·
Investor
Warren Buffett's
long-standing concerns about nuclear
proliferation were highlighted in the discussion, with observers
also noting emerging concerns over the risks posed by artificial intelligence (AI)
alongside advanced nuclear technology.
[ABS News Service/23.07.2026]
Andrew here. For years, Warren
Buffett has warned that the proliferation of nuclear weapons represents “the great
problem of mankind.” The news that the U.S. has
agreed to a broad nuclear agreement with Saudi Arabia is likely to cause consternation
in Omaha. It should also prompt the rest of the world to consider the implications.
Buffett once said, “We can’t put the genie back in the bottle — but
we can keep that genie contained.” The deal will likely mean billions of dollars
for U.S. companies, but lawmakers in the U.S. and in Israel are raising questions.
One other issue to consider: Buffett recently said that A.I. may
represent as big of a risk as nuclear weapons. Now think of the combined risk, in
light of OpenAI’s admission on Tuesday that two of its models broke out of their
“sandbox” and hacked another company to cheat on a test. More below.
Trade is back on President Trump’s agenda, with new threats against Canada on billions of dollars’
worth of goods, and a major nuclear accord with Saudi Arabia.
The moves reflect a return to the Trump administration’s approach
of carrots for favored allies and threats of stiff tariffs
to intimidate others into acquiescence. But many of the administration’s moves carry
big risks, experts say.
Example A: Saudi Arabia. The administration
is expected to announce on Wednesday a broad accord that could let the Middle Eastern country eventually enrich its
own uranium, according to The Times and others.
The long-discussed proposal — initially broached during the first
Trump administration — is meant to tighten ties with the Saudis as the war with
Iran has strained relations. But it’s also expected to give U.S. nuclear companies,
including Westinghouse, billions of dollars worth of contracts.
More money could come if, after the conclusion of a two-year study,
Washington allows Riyadh to enrich nuclear material on Saudi soil. Americans would
build
an enrichment facility for the Saudis under
a “black box” arrangement that wouldn’t transfer sensitive technology to the Gulf
state, according to The Wall Street Journal.
·
Yet skeptics
worry about nuclear arms proliferation. Saudi Arabia wouldn’t be subject to the
stronger nonproliferation terms that the U.S. required
of the United Arab Emirates in a 2009 nuclear deal.
Example B: generic drugs. Makers of generic pharmaceuticals must onshore their manufacturing
to the U.S. within two years, or face a 100 percent
tariff starting in 2028, President Trump
wrote on Truth Social on Tuesday. (It would go up to 200 percent in 2029.)
Analysts warn that the threat could push
up treatment costs for millions of Americans, instead
of fulfilling Trump’s promise of lower drug costs.
Andrew here. For years, Warren Buffett has warned that the proliferation
of nuclear weapons represents “the great problem of mankind.” The news
that the U.S. has agreed to a broad nuclear agreement with Saudi Arabia is likely
to cause consternation in Omaha. It should also prompt the rest of the world to
consider the implications.
Buffett once said, “We can’t put the genie back in the bottle — but
we can keep that genie contained.” The deal will likely mean billions of dollars
for U.S. companies, but lawmakers in the U.S. and in Israel are raising questions.
One other issue to consider: Buffett recently said that A.I. may
represent as big of a risk as nuclear weapons. Now think of the combined risk, in
light of OpenAI’s admission on Tuesday that two of its models broke out of their
“sandbox” and hacked another company to cheat on a test. More below.
Trade is back on President Trump’s agenda, with new threats against Canada on billions of dollars’
worth of goods, and a major nuclear accord with Saudi Arabia.
The moves reflect a return to the Trump administration’s approach
of carrots for favored allies and threats of stiff tariffs
to intimidate others into acquiescence. But many of the administration’s moves carry
big risks, experts say.
Example A: Saudi Arabia. The administration
is expected to announce on Wednesday a broad accord that could let the Middle Eastern country eventually enrich its
own uranium, according to The Times and others.
The long-discussed proposal — initially broached during the first
Trump administration — is meant to tighten ties with the Saudis as the war with
Iran has strained relations. But it’s also expected to give U.S. nuclear companies,
including Westinghouse, billions of dollars worth of contracts.
More money could come if, after the conclusion of a two-year study,
Washington allows Riyadh to enrich nuclear material on Saudi soil. Americans would
build
an enrichment facility for the Saudis under
a “black box” arrangement that wouldn’t transfer sensitive technology to the Gulf
state, according to The Wall Street Journal.
·
Yet skeptics
worry about nuclear arms proliferation. Saudi Arabia wouldn’t be subject to the
stronger nonproliferation terms that the U.S. required
of the United Arab Emirates in a 2009 nuclear deal.
Example B: generic drugs. Makers of generic pharmaceuticals must onshore their manufacturing
to the U.S. within two years, or face a 100 percent
tariff starting in 2028, President Trump
wrote on Truth Social on Tuesday. (It would go up to 200 percent in 2029.)
Analysts warn that the threat could push
up treatment costs for millions of Americans, instead
of fulfilling Trump’s promise of lower drug costs.
Andrew here. For years, Warren
Buffett has warned that the proliferation of nuclear weapons represents “the great
problem of mankind.” The news that the U.S. has
agreed to a broad nuclear agreement with Saudi Arabia is likely to cause consternation
in Omaha. It should also prompt the rest of the world to consider the implications.
Buffett once said, “We can’t put the genie back in the bottle — but
we can keep that genie contained.” The deal will likely mean billions of dollars
for U.S. companies, but lawmakers in the U.S. and in Israel are raising questions.
One other issue to consider: Buffett recently said that A.I. may
represent as big of a risk as nuclear weapons. Now think of the combined risk, in
light of OpenAI’s admission on Tuesday that two of its models broke out of their
“sandbox” and hacked another company to cheat on a test. More below.
Trade is back on President Trump’s agenda, with new threats against Canada on billions of dollars’
worth of goods, and a major nuclear accord with Saudi Arabia.
The moves reflect a return to the Trump administration’s approach
of carrots for favored allies and threats of stiff tariffs
to intimidate others into acquiescence. But many of the administration’s moves carry
big risks, experts say.
Example A: Saudi Arabia. The administration
is expected to announce on Wednesday a broad accord that could let the Middle Eastern country eventually enrich its
own uranium, according to The Times and others.
The long-discussed proposal — initially broached during the first
Trump administration — is meant to tighten ties with the Saudis as the war with
Iran has strained relations. But it’s also expected to give U.S. nuclear companies,
including Westinghouse, billions of dollars worth of contracts.
More money could come if, after the conclusion of a two-year study,
Washington allows Riyadh to enrich nuclear material on Saudi soil. Americans would
build
an enrichment facility for the Saudis under
a “black box” arrangement that wouldn’t transfer sensitive technology to the Gulf
state, according to The Wall Street Journal.
·
Yet skeptics
worry about nuclear arms proliferation. Saudi Arabia wouldn’t be subject to the
stronger nonproliferation terms that the U.S. required
of the United Arab Emirates in a 2009 nuclear deal.
Example B: generic drugs. Makers of generic pharmaceuticals must onshore their manufacturing
to the U.S. within two years, or face a 100 percent
tariff starting in 2028, President Trump
wrote on Truth Social on Tuesday. (It would go up to 200 percent in 2029.)
Analysts warn that the threat could push
up treatment costs for millions of Americans, instead
of fulfilling Trump’s promise of lower drug costs.